Clinical Roundup Yale Cancer Center study: For Medicaid-covered patients with cancer, insurance does not always mean access July 22, 2022Vol.48 No.29
Clinical Roundup Merck to stop phase III LYNK-003 trial evaluating Lynparza with or without bevacizumab in metastatic colorectal cancer July 22, 2022Vol.48 No.29
Clinical Roundup Multi-ethnic study uncovers unique origins of melanoma types and actionable molecular targets July 22, 2022Vol.48 No.29
Drugs & Targets FDA grants eltanexor with fast track designation; EU Commission designates eltanexor as an orphan medicinal product July 22, 2022Vol.48 No.29
In Brief The Mark Foundation for Cancer Research funds eight research projects with $2 million in ASPIRE grants July 15, 2022Vol.48 No.28
In Brief St. Jude expands strategic plan to target pediatric catastrophic diseases July 15, 2022Vol.48 No.28
In Brief Donna Hansel named division head of pathology and laboratory medicine at MD Anderson July 15, 2022Vol.48 No.28
In Brief Kimberly Hoggatt Krumwiede named dean of MD Anderson’s School of Health Professions July 15, 2022Vol.48 No.28
In Brief Howard Sandler named president-elect of ASTRO; seven members elected to board of directors July 15, 2022Vol.48 No.28
In Brief ACS CAN survey: Voters want government to focus on affordable health care July 15, 2022Vol.48 No.28
